Researchers pinpoint nongenetic mechanisms in lung cancer resistance to one commonly used therapy

United States News News

Researchers pinpoint nongenetic mechanisms in lung cancer resistance to one commonly used therapy
United States Latest News,United States Headlines
  • 📰 medical_xpress
  • ⏱ Reading Time:
  • 58 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 26%
  • Publisher: 51%

In a recent study led by Ravi Salgia, M.D., Ph.D.

retrieved 14 October 2023 from https://medicalxpress.com/news/2023-10-nongenetic-mechanisms-lung-cancer-resistance.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.Apr 6, 2021Use this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page. For general inquiries, please use ourThank you for taking time to provide your feedback to the editors.

Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.to let the recipient know who sent the email. Neither your address nor the recipient's address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Medical Xpress in any form.Get weekly and/or daily updates delivered to your inbox.

This site uses cookies to assist with navigation, analyse your use of our services, collect data for ads personalisation and provide content from third parties. By using our site, you acknowledge that you have read and understand our

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

medical_xpress /  🏆 101. in UK

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Researchers work to preserve fertility for people undergoing gene therapyResearchers work to preserve fertility for people undergoing gene therapyResearchers at the National Institutes of Health have created a novel gene therapy procedure that could preserve fertility in people with sickle cell disease and other genetic blood conditions.
Read more »

Researchers suggest new approach for testing treatments for osteoarthritisResearchers suggest new approach for testing treatments for osteoarthritisOsteoarthritis (OA) is the most common form of arthritis and is among the top 10 conditions contributing to Years Lived with Disability—a measure reflecting the impact an illness has on quality of life before it resolves or leads to death. To date, no treatments are approved that slow disease progression.
Read more »

Researchers call for urgent improvement in pain management for inflammatory arthritis patientsResearchers call for urgent improvement in pain management for inflammatory arthritis patientsResearchers from Keele University's School of Medicine have found that analgesic medicines - commonly known as 'painkillers' - are widely prescribed to people with inflammatory arthritis across England despite little research evidence that they improve pain for these patients, and studies showing they can cause serious side-effects.
Read more »

Researchers develop technology to tabulate and characterize every cell in the human brainResearchers develop technology to tabulate and characterize every cell in the human brainThe brain is made up of numerous types of cells that are organized into different structures and regions.
Read more »

Researchers show 'cryptic' viral peptide drives large part of immune response in influenza A virus infectionResearchers show 'cryptic' viral peptide drives large part of immune response in influenza A virus infectionConventional wisdom lays out two major roles for the major histocompatibility complex (MHC): Class I MHC (MHC-I) displays peptide fragments of proteins from within the cell on the cell surface and elicits a response from cytotoxic T cells (CD8 T cells), and class II MHC (MHC-II) does the same for helper T cells (CD4 T cells).
Read more »

Mount Sinai researchers receive NIH grant to compare new treatment options for sickle cell diseaseMount Sinai researchers receive NIH grant to compare new treatment options for sickle cell diseaseThe Mount Sinai Health System has received a $12,180,625 grant from the National Heart, Lung and Blood Institute to compare new treatment options for sickle cell disease and determine which work best for specific patients.
Read more »



Render Time: 2025-02-28 00:18:37